Rezolute RZLT
NASDAQ RZLT
$4.59 +0.05 (+0.99%)
As of: Sep 4, 2026 · 3:18 PM EDT

Rezolute (RZLT) Retained Earnings (2011 - 2026)

Rezolute (RZLT) posted Retained Earnings of -$461.0 million for Q1 2026, down 980846.81% sequentially from $47000.0 in Q4 2025, and down 21.47% YoY from -$587.0 million in Q1 2025.

Analysis

Rezolute (RZLT) Retained Earnings (2011 - 2026) Analysis & Trends

Rezolute has reported Retained Earnings for 16 years, with the latest figure at -$461.0 million in Q1 2026.

  • Quarterly Retained Earnings fell 21.47% year-over-year to -$461.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$461.0 million (down 21.47% YoY) and the FY2025 annual result came in at $565.9 million, up 716432.91% from the prior year.
  • Retained Earnings retreated to -$461.0 million in Q1 2026 per RZLT's latest filing, from $47000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $569.0 million in Q3 2025 and troughed at -$461.0 million in Q1 2026.
  • A 5-year average of -$40.5 million and a median of -$219.0 million in 2022 frame the typical range for Retained Earnings.
  • The widest YoY moves for Retained Earnings: up 716432.91% in 2025, down 200.56% in 2025.
  • Over 5 years, Retained Earnings stood at -$232.6 million in 2022, then fell by 24.43% to -$289.4 million in 2023, then retreated by 24.6% to -$360.6 million in 2024, then surged by 100.01% to $47000.0 in 2025, then tumbled by 980846.81% to -$461.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$461.0 million, $47000.0, and $569.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 558.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -4.00 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 4.38 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
10 Rezolute 477.02 Mn 477.02 Mn - 577.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 577.80 Mn
Dec 31, 2025 572.64 Mn
Sep 30, 2025 569.03 Mn
Jun 30, 2025 565.90 Mn
Mar 31, 2025 461.93 Mn
Dec 31, 2024 460.02 Mn
Sep 30, 2024 457.92 Mn
Jun 30, 2024 450.47 Mn
Mar 31, 2024 377.37 Mn
Dec 31, 2023 381.15 Mn
Sep 30, 2023 379.32 Mn
Jun 30, 2023 377.47 Mn
Mar 31, 2023 375.67 Mn
Dec 31, 2022 373.81 Mn
Sep 30, 2022 372.08 Mn
Jun 30, 2022 358.64 Mn
Mar 31, 2022 251.67 Mn
Dec 31, 2021 250.82 Mn
Sep 30, 2021 197.52 Mn
Jun 30, 2021 194.23 Mn